Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression
- PMID: 12964119
- DOI: 10.1086/377645
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression
Erratum in
- J Infect Dis. 2003 Dec 15;188(12):1961
Abstract
The present study assessed antiviral T cell immune responses in 48 human immunodeficiency virus (HIV)-infected children with a stable or decreasing CD4(+) T cell counts and different levels of viral control, in the presence or absence of antiretroviral therapy. Children with full (<40 copies/mL) or partial (<50,000 copies/mL) virus suppression and with a history of stable CD4(+) T cell counts had significantly increased levels of anti-HIV CD4(+) T cell lymphoproliferative responses, lower levels of CD38(+), and higher CD8(+)/CD28(+) T cell percentage, compared with those in treated children with a lack of virus suppression (>50,000 copies/mL). Levels of anti-HIV CD8(+) T cell activity, although higher in treated children with a lack of virus suppression, were not significantly different between the groups. Although levels of anti-HIV CD4(+) and CD8(+) T cell responses were not associated, these levels of responses were associated with the percentage of specific T cell subsets. Overall, a history of stable CD4(+) T cell counts, as a result of therapy that imparted full or partial virus suppression, was associated with increased levels of anti-HIV CD4(+) T helper responses and decreased T cell activation.
Similar articles
-
HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21. doi: 10.1002/cyto.b.20152. Cytometry B Clin Cytom. 2007. PMID: 17041945 Clinical Trial.
-
Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.J Infect Dis. 2001 May 15;183(10):1522-5. doi: 10.1086/320193. Epub 2001 Apr 17. J Infect Dis. 2001. PMID: 11319689
-
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.J Infect Dis. 2006 Sep 1;194(5):661-5. doi: 10.1086/505913. Epub 2006 Jul 28. J Infect Dis. 2006. PMID: 16897665
-
Mechanisms of loss of HIV-1-specific T-cell responses.J HIV Ther. 2002 May;7(2):30-4. J HIV Ther. 2002. PMID: 12553685 Review.
-
Cellular immune responses to HIV.Nature. 2001 Apr 19;410(6831):980-7. doi: 10.1038/35073658. Nature. 2001. PMID: 11309628 Review.
Cited by
-
Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control.Commun Med (Lond). 2022;2:25. doi: 10.1038/s43856-022-00085-9. Epub 2022 Mar 4. Commun Med (Lond). 2022. PMID: 35434722 Free PMC article.
-
Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.PLoS One. 2015 Dec 9;10(12):e0144706. doi: 10.1371/journal.pone.0144706. eCollection 2015. PLoS One. 2015. PMID: 26650393 Free PMC article.
-
Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?Clin Exp Immunol. 2011 Jul;165(1):77-84. doi: 10.1111/j.1365-2249.2011.04403.x. Epub 2011 Apr 19. Clin Exp Immunol. 2011. PMID: 21501151 Free PMC article.
-
Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate.J Virol. 2010 Jan;84(1):492-502. doi: 10.1128/JVI.01743-09. J Virol. 2010. PMID: 19828603 Free PMC article.
-
Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.Clin Vaccine Immunol. 2006 Jan;13(1):26-32. doi: 10.1128/CVI.13.1.26-32.2006. Clin Vaccine Immunol. 2006. PMID: 16425996 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials